NO326141B1 - Fremgangsmate for behandling av isolert systolisk hypertensjon - Google Patents
Fremgangsmate for behandling av isolert systolisk hypertensjon Download PDFInfo
- Publication number
- NO326141B1 NO326141B1 NO19995797A NO995797A NO326141B1 NO 326141 B1 NO326141 B1 NO 326141B1 NO 19995797 A NO19995797 A NO 19995797A NO 995797 A NO995797 A NO 995797A NO 326141 B1 NO326141 B1 NO 326141B1
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- procedure
- systolic hypertension
- isolated systolic
- isolated
- Prior art date
Links
- 206010042957 Systolic hypertension Diseases 0.000 title claims 3
- 239000002080 C09CA02 - Eprosartan Substances 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- OROAFUQRIXKEMV-LDADJPATSA-N eprosartan Chemical compound C=1C=C(C(O)=O)C=CC=1CN1C(CCCC)=NC=C1\C=C(C(O)=O)/CC1=CC=CS1 OROAFUQRIXKEMV-LDADJPATSA-N 0.000 claims 2
- 229960004563 eprosartan Drugs 0.000 claims 2
- 239000002775 capsule Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Fixed Capacitors And Capacitor Manufacturing Machines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4780097P | 1997-05-27 | 1997-05-27 | |
PCT/US1998/010794 WO1998053816A1 (en) | 1997-05-27 | 1998-05-27 | Method of treating isolated systolic hypertension |
Publications (3)
Publication Number | Publication Date |
---|---|
NO995797L NO995797L (no) | 1999-11-26 |
NO995797D0 NO995797D0 (no) | 1999-11-26 |
NO326141B1 true NO326141B1 (no) | 2008-10-06 |
Family
ID=21951046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19995797A NO326141B1 (no) | 1997-05-27 | 1999-11-26 | Fremgangsmate for behandling av isolert systolisk hypertensjon |
Country Status (24)
Country | Link |
---|---|
US (1) | US20020040045A1 (pt) |
EP (1) | EP1003506B1 (pt) |
JP (1) | JP2002500673A (pt) |
KR (1) | KR20010013014A (pt) |
CN (1) | CN1257427A (pt) |
AR (1) | AR012872A1 (pt) |
AT (1) | ATE307580T1 (pt) |
AU (1) | AU740646B2 (pt) |
BR (1) | BR9809611A (pt) |
CA (1) | CA2288722C (pt) |
CZ (1) | CZ298390B6 (pt) |
DE (1) | DE69832075T2 (pt) |
ES (1) | ES2251083T3 (pt) |
HU (1) | HUP0003249A3 (pt) |
IL (1) | IL132154A (pt) |
MX (1) | MXPA99010970A (pt) |
NO (1) | NO326141B1 (pt) |
NZ (1) | NZ337888A (pt) |
PL (1) | PL191971B1 (pt) |
SA (1) | SA98190174B1 (pt) |
TR (1) | TR199902914T2 (pt) |
TW (1) | TW579296B (pt) |
WO (1) | WO1998053816A1 (pt) |
ZA (1) | ZA984421B (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060160871A1 (en) * | 2004-12-07 | 2006-07-20 | Nektar Therapeutics | Stable non-crystalline formulation comprising losartan |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US544080A (en) * | 1895-08-06 | Centrifugal filtering-machine | ||
US5418250A (en) * | 1989-06-14 | 1995-05-23 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists |
US5185351A (en) * | 1989-06-14 | 1993-02-09 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists |
JPH05199342A (ja) * | 1991-05-20 | 1993-08-06 | Xerox Corp | 無声の手書きによる携帯式通信装置および方法 |
-
1998
- 1998-05-25 ZA ZA984421A patent/ZA984421B/xx unknown
- 1998-05-27 TW TW087108204A patent/TW579296B/zh not_active IP Right Cessation
- 1998-05-27 HU HU0003249A patent/HUP0003249A3/hu unknown
- 1998-05-27 PL PL336886A patent/PL191971B1/pl not_active IP Right Cessation
- 1998-05-27 KR KR1019997010988A patent/KR20010013014A/ko not_active Application Discontinuation
- 1998-05-27 TR TR1999/02914T patent/TR199902914T2/xx unknown
- 1998-05-27 JP JP50086599A patent/JP2002500673A/ja active Pending
- 1998-05-27 ES ES98923815T patent/ES2251083T3/es not_active Expired - Lifetime
- 1998-05-27 CA CA002288722A patent/CA2288722C/en not_active Expired - Fee Related
- 1998-05-27 AT AT98923815T patent/ATE307580T1/de not_active IP Right Cessation
- 1998-05-27 AU AU76017/98A patent/AU740646B2/en not_active Ceased
- 1998-05-27 BR BR9809611-7A patent/BR9809611A/pt not_active Application Discontinuation
- 1998-05-27 AR ARP980102464A patent/AR012872A1/es not_active Application Discontinuation
- 1998-05-27 IL IL13215498A patent/IL132154A/en not_active IP Right Cessation
- 1998-05-27 CN CN98805305A patent/CN1257427A/zh active Pending
- 1998-05-27 WO PCT/US1998/010794 patent/WO1998053816A1/en active IP Right Grant
- 1998-05-27 NZ NZ337888A patent/NZ337888A/en unknown
- 1998-05-27 DE DE69832075T patent/DE69832075T2/de not_active Expired - Lifetime
- 1998-05-27 MX MXPA99010970A patent/MXPA99010970A/es not_active IP Right Cessation
- 1998-05-27 CZ CZ0420099A patent/CZ298390B6/cs not_active IP Right Cessation
- 1998-05-27 EP EP98923815A patent/EP1003506B1/en not_active Expired - Lifetime
- 1998-06-17 SA SA98190174A patent/SA98190174B1/ar unknown
-
1999
- 1999-11-26 NO NO19995797A patent/NO326141B1/no not_active IP Right Cessation
-
2001
- 2001-10-24 US US09/999,808 patent/US20020040045A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
KR20010013014A (ko) | 2001-02-26 |
CN1257427A (zh) | 2000-06-21 |
JP2002500673A (ja) | 2002-01-08 |
HUP0003249A2 (hu) | 2002-01-28 |
ATE307580T1 (de) | 2005-11-15 |
SA98190174B1 (ar) | 2006-05-13 |
AU7601798A (en) | 1998-12-30 |
ES2251083T3 (es) | 2006-04-16 |
WO1998053816A1 (en) | 1998-12-03 |
TR199902914T2 (xx) | 2000-06-21 |
MXPA99010970A (es) | 2005-07-25 |
AR012872A1 (es) | 2000-11-22 |
NO995797L (no) | 1999-11-26 |
EP1003506B1 (en) | 2005-10-26 |
CA2288722C (en) | 2007-04-24 |
BR9809611A (pt) | 2000-07-04 |
EP1003506A1 (en) | 2000-05-31 |
AU740646B2 (en) | 2001-11-08 |
CZ298390B6 (cs) | 2007-09-19 |
IL132154A0 (en) | 2001-03-19 |
HUP0003249A3 (en) | 2002-02-28 |
CZ420099A3 (cs) | 2000-09-13 |
ZA984421B (en) | 1998-11-27 |
NZ337888A (en) | 2001-04-27 |
TW579296B (en) | 2004-03-11 |
IL132154A (en) | 2002-12-01 |
DE69832075D1 (de) | 2005-12-01 |
PL336886A1 (en) | 2000-07-17 |
CA2288722A1 (en) | 1998-12-03 |
DE69832075T2 (de) | 2006-07-13 |
PL191971B1 (pl) | 2006-07-31 |
US20020040045A1 (en) | 2002-04-04 |
NO995797D0 (no) | 1999-11-26 |
EP1003506A4 (en) | 2000-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU94032150A (ru) | Лекарственное средство с замедленным высвобождением активно-действующего вещества | |
HUP0003173A2 (hu) | A GLP-1 vagy analógjainak alkalmazása szívizominfarktus kezelésére használható gyógyszerkészítmények előállítására | |
NO883667D0 (no) | Kapsel for farmasoeytisk virksomme innholdsstoffer av en droge. | |
CA2258095A1 (en) | Tetrahydrolipstatin containing compositions | |
HUP0101598A2 (hu) | Aszpartil proteáz inhibitorok prodrugjai és ezeket tartalmazó gyógyszerkészítmények | |
IT1245761B (it) | Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale. | |
IS1858B (is) | Aðferð til að framleiða lyfjablöndu á formi smápilla til að meðhöndla þarmabólgur | |
ATE81287T1 (de) | Am zielorgan wirkendes enterales abgabesystem. | |
CA2307018A1 (en) | Osmotic medicament releasing system | |
CA2326517A1 (en) | New galenic preparations of meloxicam for oral administration | |
RU93036959A (ru) | Свободно растворимый лекарственный препарат с замедленным действием биологически активных веществ, назначенный для приема внутрь, способ его производства | |
ATA285187A (de) | Substituierte alpha-aminosaeuren, ihre herstellung und diese enthaltende arzneimittel | |
NO20006352L (no) | Anvendelse av diazepiner til fremstilling av medisiner for behandling av patologiske tilstander eller sykdommer som involverer en av veksthormon-frigjöringsinhiberingsfaktor- reseptorene | |
ZA975827B (en) | Stable medicament with benzimidazole derivatives as an active ingredient for oral administration and method for its production. | |
NZ229518A (en) | Pharmaceutical dosage form for the medication of fish: method of administration and (prophylactic) treatment | |
CA2283408A1 (en) | Swallow tablet comprising paracetamol | |
CA2383212A1 (en) | Controlled release oral dosage suitable for oral administration | |
RU95101385A (ru) | Продукты, содержащие g-csf и tnf связующие протеина | |
HUP9701777A2 (hu) | Raloxifene alkalmazása mellrák megelőzésére alkalmas gyógyszerkészítmények előállítására | |
CA2350659A1 (en) | Pharmaceutical composition for modified release insulin sensitiser | |
EP0302714A3 (en) | Pharmaceutical composition for treatment of bone-wasting diseases | |
GR3017161T3 (en) | Multi-fractionable tablet structure. | |
DE69627160D1 (de) | Pharmazeutische zusammensetzung enthaltend 3-(2,2,2-trimethylhydrazinium)proprionat und gamma-butyrobetain für die behandlung von herz-gefäss-erkrankungen | |
WO2003099214A3 (en) | Biguanide formulations | |
NO326141B1 (no) | Fremgangsmate for behandling av isolert systolisk hypertensjon |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |